Paul Bien

763 total citations
18 papers, 634 citations indexed

About

Paul Bien is a scholar working on Infectious Diseases, Epidemiology and Pharmacology. According to data from OpenAlex, Paul Bien has authored 18 papers receiving a total of 634 indexed citations (citations by other indexed papers that have themselves been cited), including 15 papers in Infectious Diseases, 8 papers in Epidemiology and 7 papers in Pharmacology. Recurrent topics in Paul Bien's work include Antifungal resistance and susceptibility (10 papers), Antimicrobial Resistance in Staphylococcus (7 papers) and Fungal Infections and Studies (6 papers). Paul Bien is often cited by papers focused on Antifungal resistance and susceptibility (10 papers), Antimicrobial Resistance in Staphylococcus (7 papers) and Fungal Infections and Studies (6 papers). Paul Bien collaborates with scholars based in United States, United Kingdom and Slovakia. Paul Bien's co-authors include Philippe Prokocimer, Michael A. Pfaller, Mariana Castanheira, Michael D. Huband, Ken Bartizal, Robert K. Flamm, Shawn D. Flanagan, Sonia L. Minassian, Chris M. Pillar and Jürgen B. Bulitta and has published in prestigious journals such as Antimicrobial Agents and Chemotherapy, Journal of Antimicrobial Chemotherapy and Pharmacotherapy The Journal of Human Pharmacology and Drug Therapy.

In The Last Decade

Paul Bien

18 papers receiving 608 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Paul Bien United States	11	512	248	152	138	113	18	634
E Huczko United States	15	317 0.6×	356 1.4×	345 2.3×	86 0.6×	273 2.4×	20	806
Laura McEntee United Kingdom	14	502 1.0×	443 1.8×	186 1.2×	23 0.2×	96 0.8×	20	711
Kim Credito United States	16	410 0.8×	318 1.3×	308 2.0×	165 1.2×	255 2.3×	27	776
Ronda L. Akins United States	12	385 0.8×	186 0.8×	245 1.6×	222 1.6×	160 1.4×	23	648
P. Hohl Switzerland	11	271 0.5×	231 0.9×	260 1.7×	97 0.7×	232 2.1×	26	578
M. Husson Belgium	13	175 0.3×	165 0.7×	205 1.3×	96 0.7×	176 1.6×	35	499
Sarah Whalley United Kingdom	13	234 0.5×	295 1.2×	185 1.2×	21 0.2×	123 1.1×	16	507
Joanne Goodwin United Kingdom	20	669 1.3×	665 2.7×	333 2.2×	25 0.2×	153 1.4×	26	972
Jamie VanHecker United States	12	304 0.6×	225 0.9×	171 1.1×	27 0.2×	119 1.1×	14	433
B Kolek United States	13	173 0.3×	206 0.8×	307 2.0×	89 0.6×	294 2.6×	16	637

Countries citing papers authored by Paul Bien

Since Specialization

Citations

This map shows the geographic impact of Paul Bien's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Paul Bien with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Paul Bien more than expected).

Fields of papers citing papers by Paul Bien

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Paul Bien. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Paul Bien. The network helps show where Paul Bien may publish in the future.

Co-authorship network of co-authors of Paul Bien

This figure shows the co-authorship network connecting the top 25 collaborators of Paul Bien. A scholar is included among the top collaborators of Paul Bien based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Paul Bien. Paul Bien is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

18 of 18 papers shown

Pfaller, Michael A., et al.. (2024). In vitro activity of manogepix and comparators against infrequently encountered yeast and mold isolates from the SENTRY Surveillance Program (2017–2022). Antimicrobial Agents and Chemotherapy. 68(2). e0113223–e0113223. 10 indexed citations

Pappas, Peter G., José A. Vázquez, Ilana Oren, et al.. (2023). Clinical safety and efficacy of novel antifungal, fosmanogepix, for the treatment of candidaemia: results from a Phase 2 trial. Journal of Antimicrobial Chemotherapy. 78(10). 2471–2480. 37 indexed citations

Vázquez, José A., Peter G. Pappas, Kenneth D Boffard, et al.. (2023). Clinical Efficacy and Safety of a Novel Antifungal, Fosmanogepix, in Patients with Candidemia Caused by Candida auris : Results from a Phase 2 Trial. Antimicrobial Agents and Chemotherapy. 67(5). e0141922–e0141922. 54 indexed citations

Pfaller, Michael A., Michael D. Huband, Paul R. Rhomberg, Paul Bien, & Mariana Castanheira. (2022). Activities of Manogepix and Comparators against 1,435 Recent Fungal Isolates Collected during an International Surveillance Program (2020). Antimicrobial Agents and Chemotherapy. 66(11). e0102822–e0102822. 19 indexed citations

Huband, Michael D., Michael A. Pfaller, Cecília G Carvalhaes, Paul Bien, & Mariana Castanheira. (2022). 2043. In Vitro Activity of Manogepix Against 2,810 Fungal Isolates from the SENTRY Surveillance Program (2020-2021) Stratified by Infection Type. Open Forum Infectious Diseases. 9(Supplement_2). 2 indexed citations

Pfaller, Michael A., Michael D. Huband, Robert K. Flamm, Paul Bien, & Mariana Castanheira. (2021). Antimicrobial activity of manogepix, a first-in-class antifungal, and comparator agents tested against contemporary invasive fungal isolates from an international surveillance programme (2018–2019). Journal of Global Antimicrobial Resistance. 26. 117–127. 43 indexed citations

Huband, Michael D., Michael A. Pfaller, Robert K. Flamm, et al.. (2020). 1260. Activity of Manogepix (APX001A) against 2,669 Fungal Isolates from the SENTRY Surveillance Program (2018-2019) Stratified by Infection Type. Open Forum Infectious Diseases. 7(Supplement_1). S646–S647. 2 indexed citations

Pfaller, Michael A., Michael D. Huband, Robert K. Flamm, Paul Bien, & Mariana Castanheira. (2019). In Vitro Activity of APX001A (Manogepix) and Comparator Agents against 1,706 Fungal Isolates Collected during an International Surveillance Program in 2017. Antimicrobial Agents and Chemotherapy. 63(8). 67 indexed citations

Bien, Paul, Carisa De Anda, & Philippe Prokocimer. (2014). Comparison of Digital Planimetry and Ruler Technique To Measure ABSSSI Lesion Sizes in the ESTABLISH–1 Study. Surgical Infections. 15(2). 105–110. 8 indexed citations

10.

Sahm, Daniel F., Jennifer Deane, Paul Bien, et al.. (2014). Results of the Surveillance of Tedizolid Activity and Resistance Program: in vitro susceptibility of Gram-positive pathogens collected in 2011 and 2012 from the United States and Europe. Diagnostic Microbiology and Infectious Disease. 81(2). 112–118. 61 indexed citations

11.

Zurenko, Gary E., et al.. (2014). Use of linezolid susceptibility test results as a surrogate for the susceptibility of Gram-positive pathogens to tedizolid, a novel oxazolidinone. Annals of Clinical Microbiology and Antimicrobials. 13(1). 46–46. 25 indexed citations

12.

Flanagan, Shawn D., et al.. (2013). Pharmacokinetics of Tedizolid Following Oral Administration: Single and Multiple Dose, Effect of Food, and Comparison of Two Solid Forms of the Prodrug. Pharmacotherapy The Journal of Human Pharmacology and Drug Therapy. 34(3). 240–250. 83 indexed citations

13.

Prokocimer, Philippe, et al.. (2012). In Vitro Activity and Microbiological Efficacy of Tedizolid (TR-700) against Gram-Positive Clinical Isolates from a Phase 2 Study of Oral Tedizolid Phosphate (TR-701) in Patients with Complicated Skin and Skin Structure Infections. Antimicrobial Agents and Chemotherapy. 56(9). 4608–4613. 77 indexed citations

14.

Prokocimer, Philippe, Paul Bien, Joseph Surber, et al.. (2010). Phase 2, Randomized, Double-Blind, Dose-Ranging Study Evaluating the Safety, Tolerability, Population Pharmacokinetics, and Efficacy of Oral Torezolid Phosphate in Patients with Complicated Skin and Skin Structure Infections. Antimicrobial Agents and Chemotherapy. 55(2). 583–592. 97 indexed citations

15.

Bien, Paul. (2008). Human Pharmacokinetics of TR-700 after Ascending Single Oral Doses of the Prodrug TR-701, a Novel Oxazolidinone Antibiotic. 46th Annual Meeting. 6 indexed citations

16.

Heifetz, Carl L., Paul Bien, Michael Cohen, et al.. (1988). Enoxacin: in-vitro and animal evaluation as a parenteral and oral agent against hospital bacterial isolates. Journal of Antimicrobial Chemotherapy. 21(suppl B). 29–42. 10 indexed citations

17.

Sugar, Alan M., Michael Cohen, Paul Bien, et al.. (1986). Treatment of Experimental Pseudomonas Corneal Ulcers With Enoxacin, a Quinolone Antibiotic. Archives of Ophthalmology. 104(8). 1230–1232. 5 indexed citations

18.

Cohen, Michael, Timothy J. Griffin, Paul Bien, Carl L. Heifetz, & J. M. DOMAGALA. (1985). In vitro activity of CI-934, a quinolone carboxylic acid active against gram-positive and -negative bacteria. Antimicrobial Agents and Chemotherapy. 28(6). 766–772. 28 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact